| Pharmaceutical active ingredients: |
| Clofibrate |
| Available forms, composition and doses of Cartagyl: |
| N / A |
| Cartagyl medical category: |
| Human:Fribic Acid derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C10AB01 - Clofibrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Carrtime | Dextroamphetamine | Unidentified Pharmaceutical Company |
| Carsodal | Carisoprodol | Unidentified Pharmaceutical Company |
| Carsodol | Carisoprodol | Unidentified Pharmaceutical Company |
| Carsonol | Laureth-9 | Unidentified Pharmaceutical Company |
| Cartagine | Ajmaline | Unidentified Pharmaceutical Company |
| Cartancyl | Prednisone | Unidentified Pharmaceutical Company |
| Cartazyme MP | Hemicellulase | Unidentified Pharmaceutical Company |
| Cartose | Dextrose | Unidentified Pharmaceutical Company |
| Cartric | Rescinnamine | Unidentified Pharmaceutical Company |
| Carvacron | Trichlormethiazide | Unidentified Pharmaceutical Company |